Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury.

Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury. Bone. 2007 Aug; 41(2):297-302.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.